🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

45 results for “HALOZYME THERAPEUTICS, INC.” Clear

  1. Ondansetron

    HALOZYME THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  2. PEGPH20

    HALOZYME THERAPEUTICS, INC.

    Solid Tumor

    phase 1 small molecule completed

    2 trials

  3. PEGPH20

    HALOZYME THERAPEUTICS, INC.

    Cholangiocarcinoma Non-resectable

    phase 1 small molecule terminated

    1 trial

  4. PEGPH20

    HALOZYME THERAPEUTICS, INC.

    NSCLC

    phase 1 small molecule completed

    1 trial

  5. PEGylated recombinant human hyaluronidase PH20

    HALOZYME THERAPEUTICS, INC.

    Non-small Cell Lung Cancer

    phase 1 small molecule terminated

    1 trial

  6. Recombinant human hyaluronidase PH20 (rHuPH20)

    HALOZYME THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  7. SC HYLENEX and Ceftriaxone

    HALOZYME THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial

  8. rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Risk Factors for or a Diagnosis of Osteoporosis

    phase 1 small molecule completed

    1 trial

  9. rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

  10. Commercial Hylenex® recombinant (hyaluronidase human injection)

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  11. Hylenex

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    2 trials

  12. Isotonic hydration fluid and recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

  13. Rapid Acting insulin with pre-treatment of rHuPH20

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  14. Sham Injection

    HALOZYME THERAPEUTICS, INC.

    Type 1 Diabetes Mellitus

    approved small molecule completed

    1 trial

  15. Subcutaneous HYLENEX (recombinant human hyaluronidase) and Lactated Ringer's solution

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule terminated

    1 trial

  16. hyaluronidase (human recombinant)/rehydration fluid

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  17. hylenex-facilitated subcutaneous Lactated Ringer's infusion

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  18. large protein molecule

    HALOZYME THERAPEUTICS, INC.

    Rheumatoid Arthritis

    approved small molecule completed

    1 trial

  19. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Healthy

    approved small molecule completed

    1 trial

  20. recombinant human hyaluronidase

    HALOZYME THERAPEUTICS, INC.

    Dehydration

    approved small molecule completed

    1 trial

  21. Gemcitabine

    HALOZYME THERAPEUTICS, INC.

    Pancreatic Cancer

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources